Products
Platform
Research
Market
Learn
Compare Nippon India Pharma Fund vs Tata India Pharma & Healthcare Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 3.0 |
Min SIP Amount | ₹100 | ₹100 |
Expense Ratio | 1.8 | 2.1 |
NAV | ₹508.05 | ₹30.40 |
Fund Started | 10 May 2004 | 04 Dec 2015 |
Fund Size | ₹8736.57 Cr | ₹1339.00 Cr |
Exit Load | Exit load of 1% if redeemed within 1 month. | Exit load of 0.25% if redeemed within 30 days. |
Risk
Very High
Very High
Rating
3.0
3.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.8
2.1
NAV
₹508.05
₹30.40
Fund Started
10 May 2004
04 Dec 2015
Fund Size
₹8736.57 Cr
₹1339.00 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 0.25% if redeemed within 30 days.
Returns
1 Year | -2.06% | -1.69% |
3 Year | 22.52% | 23.17% |
5 Year | 19.01% | 19.33% |
1 Year
-2.06%
-1.69%
3 Year
22.52%
23.17%
5 Year
19.01%
19.33%
Holding Analysis
Equity | 99.45% | 93.81% |
Cash | 0.55% | 6.19% |
Equity
99.45%
93.81%
Cash
0.55%
6.19%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.22% |
Divi's Laboratories Ltd. | 7.55% |
Lupin Ltd. | 5.93% |
Cipla Ltd. | 5.69% |
Dr. Reddy's Laboratories Ltd. | 5.69% |
Apollo Hospitals Enterprise Ltd. | 5.57% |
Medplus Health Services Ltd. | 3.86% |
Vijaya Diagnostic Centre Ltd. | 3.55% |
Glaxosmithkline Pharmaceuticals Ltd. | 3.31% |
Gland Pharma Ltd. | 3.12% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.92% |
Cipla Ltd. | 6.62% |
Apollo Hospitals Enterprise Ltd. | 5.20% |
Lupin Ltd. | 4.77% |
Healthcare Global Enterprises Ltd. | 4.38% |
Torrent Pharmaceuticals Ltd. | 4.32% |
Aster DM Healthcare Ltd. | 4.32% |
Fortis Healthcare Ltd. | 4.00% |
Alkem Laboratories Ltd. | 4.00% |
Max Healthcare Institute Ltd. | 3.80% |
Fund Manager
Name | Akshay Sharma | Meeta Shetty |
Start Date | 01 Dec 2022 | 09 Nov 2018 |
Name
Akshay Sharma
Meeta Shetty
Start Date
01 Dec 2022
09 Nov 2018
About Fund
Description | The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies. | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. |
Launch Date | 10 May 2004 | 04 Dec 2015 |
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Launch Date
10 May 2004
04 Dec 2015
